📰 Celularity Inc News
Page 9 - Celularity Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Celularity Inc. Real-time updates on events, politics, business and more.
February 1, 2023
Increased use of amniotic products and growing research efforts in North America region is booming the market growth. Exactitude Consultancy explores the current market and explores new opportunities
January 11, 2023
/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and...
January 11, 2023
/PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and...
January 11, 2023
/PRNewswire/ -- Celularity Inc. (NASDAQ: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and...
January 11, 2023
/PRNewswire/ -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and...
January 6, 2023
/PRNewswire/ -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2023" report has been added to ResearchAndMarkets.coms...
January 6, 2023
Legacy studies employing a single treatment course of two infusions seven days apart demonstrated greatest benefit in three early studies Data support...
January 4, 2023
Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience...
December 28, 2022
/PRNewswire/ -- The "Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type...
November 10, 2022
Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced HER2 positive gastric and gastroesophageal junction...